<DOC>
	<DOCNO>NCT01729195</DOCNO>
	<brief_summary>This single-center randomized trial evaluate efficacy safety new bone screw ( antibiotic releasing bioabsorbable screw ) fixation syndesmosis patient Weber C-type ankle fracture . The comparison make subject treated conventional metal screw fixation syndesmosis . The primary objective show antibiotic release bioabsorbable screw least good routinely use metal screw prevention syndesmosis widen patient Weber C-type ankle fracture . The secondary objective show clinical outcome ankle fracture treatment equal patient treat antibiotic releasing bioabsorbable screw conventional metal screw .</brief_summary>
	<brief_title>Ankle Syndesmosis Fixation Antibiotic Releasing Bioabsorbable Screw</brief_title>
	<detailed_description>This randomize parallel-group single centre study . All patient enrol acute , close Weber C-type ankle fracture . The ankle syndesmosis fix use new medical device ( antibiotic contain bioabsorbable screw ) routinely use device ( metal screw ) . The investigational antibiotic contain bioabsorbable screw ankle syndesmosis repair ( thread diameter 4.5 mm ) make bioabsorbable poly ( lactide-co-glycolide ) ( PLGA ) 80:20 ciprofloxacin , bactericidal antibiotic . The main purpose screw prevent syndesmosis widen Weber C-type ankle fracture . The secondary function screw reduce risk colonization implant bacteria subsequently prevent biomaterial-related infection . In control group , stainless steel screw use . All patient receive standard care concomitant fracture injury ankle . The key variable assessment radiostereometric ( RSA ) measurement syndesmosis width , CT image ankle mortise standard radiographic evaluation syndesmosis width ankle mortise . Clinical outcome ankle fracture treatment measure use standardized outcome questionnaire ( RAND-36 , AAOS Foot Ankle Outcome Instrument , Olerud Molander score , VAS pain scale ) . The follow-up patient 52 week . The metal screw remove 8 week fracture surgery . The expected mechanical integrity bioabsorbable screw 6 - 8 week , complete absorption time bioabsorbable screw human body expect approximately two year</detailed_description>
	<mesh_term>Fractures , Bone</mesh_term>
	<mesh_term>Ankle Fractures</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Ciprofloxacin</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<criteria>acute , close Weber Ctype ankle fracture adult patient ( age 1870 year ) female subject childbearing potential must negative pregnancy test approve contraception study duration previous fracture infection injure ankle ipsilateral foot significant associate softtissue injury longbone fracture low extremity document active infection anatomic site know metabolic skeletal disease ( osteoporosis osteomalasia ) medication affect bone structure ( corticosteroid treatment ) pathological fracture underlie systemic disease ( unbalanced diabetes mellitus rheumatoid disease ) condition ( alcoholism drug abuse ) know affect resistance infection history prosthetic knee hip replacement pregnant woman nurse mother hypersensitivity fluoroquinolones relate antibiotic ( nalidixine acid ) condition judgment investigator would prohibit subject participate study may hinder collection data interpretation result</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>bioabsorbable implant</keyword>
	<keyword>bone screw</keyword>
	<keyword>local antibiotic prophylaxis</keyword>
	<keyword>syndesmosis injury</keyword>
	<keyword>ankle fracture</keyword>
	<keyword>ciprofloxacin</keyword>
</DOC>